Marpai, Inc. - 10-Q Filing
Marpai, Inc. reports Q3 2026 financial results with 26.9 million common shares outstanding as of November 12, 2026
Tickers: $MRAI
More Regulatory news
- Stark Novus Financial Inc. - 8-K Filing
- Starling Oncology, Inc. - 8-K Filing
- Spero Therapeutics, Inc. - 8-K Filing
- BATTALION OIL CORP - 10-Q Filing
- INNOVATIVE FOOD HOLDINGS INC - 10-Q Filing
- Silexion Therapeutics Corp - 10-Q Filing
- DiaMedica Therapeutics Inc. - 10-Q Filing
- BATTALION OIL CORP - 8-K Filing
- Algorhythm Holdings, Inc. - 8-K Filing
- AMERICAN BATTERY MATERIALS, INC. - 10-Q Filing